Secondary patents

Why Pharmaceutical Follow-On Innovation Should Be Eligible For Patent Protection

February 7, 2020

Despite the important role of intellectual property rights in incentivizing innovation, the patenting of pharmaceutical innovation is frequently accused of impeding access to medicine.

medicine capsule on an Indian Rupee note

Copy or Compete? How India’s patent law harms its own drug industry’s ability to innovate

December 3, 2018

Section 3(d) of India’s patent law may be putting India at a competitive disadvantage. The data presented in this research note shows it is preventing Indian generic pharmaceutical companies from developing new formulations, compositions, and combinations of existing medicines, which they instead undertake and commercialise abroad.

Secondary patents

Why Pharmaceutical Follow-On Innovation Should Be Eligible For Patent Protection

Copy or Compete? How India’s patent law harms its own drug industry’s ability to innovate

About

Topics

Get regular updates from Geneva Network.